Established in 2015, PT. CKD OTTO is a joint venture between Chong Kun Dang Pharm Corp. (CKD), which is the number one pharmaceutical company in Korea, with PT Otto Pharmaceutical Industries (Otto), which is a member of Indonesian leading pharmaceutical company MENSA Group.PT. CKD OTTO specialization is anti-cancer drugs as known as oncology medicines in Indonesian Market. We cooperate with many hospitals throughout Indonesia to provide the best quality of oncology medicines. Our aim in the future is not only to reach domestic market, but also to expand our market to ASEAN, MENA and EU countries. Implementing the same mission - “Better Life through Better Medicine” - as our holding company in Korea, we are eager to grow to become the number one pharmaceutical company in Indonesia.Our vision is to provide patients with better access to high-quality, cost - effective medicines in key therapeutic areas.Open Management• Contribution to society• Responsible for management• Stable financial structure• Effective management resourcesDevelopment of new drugs• Development of new drugs• Improvement of new drugs• Development of gene therapy drugs• Development of new drugs adopting biotechnology
Established in 2015, PT. CKD OTTO is a joint venture between Chong Kun Dang Pharm Corp. (CKD), which is the number one pharmaceutical company in Korea, with PT Otto Pharmaceutical Industries (Otto), which is a member of Indonesian leading pharmaceutical company MENSA Group.PT. CKD OTTO specialization is anti-cancer drugs as known as oncology medicines in Indonesian Market. We cooperate with many hospitals throughout Indonesia to provide the best quality of oncology medicines. Our aim in the future is not only to reach domestic market, but also to expand our market to ASEAN, MENA and EU countries. Implementing the same mission - “Better Life through Better Medicine” - as our holding company in Korea, we are eager to grow to become the number one pharmaceutical company in Indonesia.Our vision is to provide patients with better access to high-quality, cost - effective medicines in key therapeutic areas.Open Management• Contribution to society• Responsible for management• Stable financial structure• Effective management resourcesDevelopment of new drugs• Development of new drugs• Improvement of new drugs• Development of gene therapy drugs• Development of new drugs adopting biotechnology
Established in 2015, PT. CKD OTTO is a joint venture between Chong Kun Dang Pharm Corp. (CKD), which is the number one pharmaceutical company in Korea, with PT Otto Pharmaceutical Industries (Otto), which is a member of Indonesian leading pharmaceutical company MENSA Group.PT. CKD OTTO specialization is anti-cancer drugs as known as oncology medicines in Indonesian Market. We cooperate with many hospitals throughout Indonesia to provide the best quality of oncology medicines. Our aim in the future is not only to reach domestic market, but also to expand our market to ASEAN, MENA and EU countries. Implementing the same mission - “Better Life through Better Medicine” - as our holding company in Korea, we are eager to grow to become the number one pharmaceutical company in Indonesia.Our vision is to provide patients with better access to high-quality, cost - effective medicines in key therapeutic areas.Open Management• Contribution to society• Responsible for management• Stable financial structure• Effective management resourcesDevelopment of new drugs• Development of new drugs• Improvement of new drugs• Development of gene therapy drugs• Development of new drugs adopting biotechnology